Biologics

Spinal Implants

Investors

Corporate Profile

Xtant Medical is a global medical technology company focused on the design, manufacture and commercialization of regenerative biologics and spinal implant systems.

 

Xtant Medical Holdings, Inc. (NYSE MKT: XTNT) develops, manufactures and markets regenerative medicine products and medical devices for domestic and international markets. Xtant products serve the specialized needs of orthopedic and neurological surgeons, including orthobiologics for the promotion of bone healing, implants and instrumentation for the treatment of spinal disease, tissue grafts for the treatment of orthopedic disorders, and biologics to promote healing following cranial, and foot and ankle surgeries.

Stock Quote

Stock Quote XTNT (Common Stock)

Stocks
StockSymbolPriceChart (24H)
XTNT
Xtant Medical Holdings, Inc.
XTNT
XTNT$0.62

Sign Up for Alerts

Sign up to receive email alerts whenever Xtant Medical Holdings Inc posts new information to the site. Just enter your email address and click Submit.

Name(Required)
Email(Required)
Xtant Medical Announces Commercial Launch of its Next-Generation nanOss Strata™ Synthetic Bone Graft
Xtant Medical to Participate in the H.C. Wainwright 27th Annual Global Investment Conference
Xtant Medical Reports Second Quarter 2025 Financial Results
Xtant Medical to Attend the CG 45th Annual Growth Conference
Xtant Medical to Announce Second Quarter 2025 Financial Results on August 12, 2025

Latest News and Highlights